Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,026 public trials 2,026 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

Phase II Open Label Trial to Determine Safety & Efficacy of Tisagenlecleucel in Pediatric Non-Hodgkin Lymphoma Patients

NCT03610724

Conditions
Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +17 more
Locations
  • Childrens Hospital Los Angeles Los Angeles, California, United States
  • UCSF Medical Center San Francisco, California, United States
  • Johns Hopkins Oncology Center ORA Baltimore, Maryland, United States
  • Dana Farber Cancer Institute Dept.of DFCI Boston, Massachusetts, United States
View all 26 locations
View Trial Details
Completed

Isatuximab in Combination With Cemiplimab in Relapsed/Refractory Multiple Myeloma (RRMM) Patients

NCT03194867

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • University of Colorado-Site Number:8400001 Denver, Colorado, United States
  • University of Kansas Medical Center-Site Number:8400003 Kansas City, Kansas, United States
  • Memorial Sloan-Kettering Cancer Center-Site Number:8400002 New York, United States
  • Fox Chase Cancer Center-Site Number:8400004 Philadelphia, Pennsylvania, United States
View all 30 locations
View Trial Details
Completed

Study of ISB 1342, a CD38/CD3 Bispecific Antibody, in Subjects With Previously Treated Multiple Myeloma

NCT03309111

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • Johns Hopkins Medicine - The Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States
  • Mayo Clinic Cancer Center (MCCC) - Rochester Rochester, Minnesota, United States
  • Hackensack University Medical Center Hackensack, New Jersey, United States
View all 20 locations
View Trial Details

Related conditions